Intracranial Subdural Empyema – A Mini Review

Joseph Yoon1*, Claire Maree O’Bryan3, Michael Redmond1,2

1Department of Neurosurgery, Royal Darwin Hospital, Darwin, Northern Territory, Australia

2Kenneth G Jamieson Department of Neurosurgery, Royal Brisbane and Women’s Hospital, Brisbane, Queensland, Australia

3Flinders University, Darwin, Northern Territory, Australia


Intracranial subdural empyema is a rare but devastating infection of the brain. With improvements in investigations and treatment, the previously seen mortality of 100% has now been reduced to 4-9%. The underlying factor in this improvement is the reduction in time to treat. To achieve this, the first barrier is identifying the possibility of the condition. There have been multiple case reports, series, and retrospective studies on the matter, but over time the clinical epidemiology has changed. In this report, we give a up to date review of the infection and highlight the important features clinicians should consider when assessing patients with possible intracranial subdural empyema.


Intracranial subdural empyema (ISE) is a rare but serious infection of the brain with the purulent collection located within the space between dura and arachnoid mater. Prior to the advent of antibiotics, morbidity, and mortality affected near 100% of patients within 24-48 hours of presentation1-7. The combination of improvement of investigations and management strategies have decreased mortality to 4-9%6–9. This is largely credited to decreased time to diagnosis and a subsequent reduction in the time to treatment7,10,11. The aim of this report is to summarize the key clinical features of ISE and assist in management for clinicians faced with this challenging condition.

ISE can occur in any age group, gender or population3,6,8,12–15. Studies have shown two distinct populations at risk of ISE. The first group are children and young adults (<20 years of age) with males being at a higher risk2–4,6,8,15–17. This demographic has a strong association with sinusitis and otogenic infections (41-78% of cases) highlighting the likely pathogenic roles of these diseases to ISE6,13,15–18. Other, but less frequently mentioned causes included meningitis, neurosurgical procedures, and head trauma15,19,20. The relationship of the younger population, sinus/otogenic infections and ISE can be explained by a combination of anatomical and behavioral risk factors. The younger male population possesses a relatively higher risk to develop sinusitis, meningitis, otitis media and undergo trauma compared to their older and female counterparts4,17,21. Some authors deduct this to be a possible consequence of the male population’s greater risk of neglecting infections and higher risk taking behaviour3,6,22. Anatomical differences in the greater vascularity of the diploic veins in the younger male may also increase the risk of septic embolism and subsequent ISE compared to the older and female counterparts12.

The second group are older with dissimilar associated risk and again a slight male predisposition2-4,6,8,9,11,17,18,20,23. In this group patients tend to be older (age 40-50) and associated more with neurosurgical procedures compared to diseases of the ear, nose and throat2–6,8,17,20. This group was likely under-recognized secondary to the volume of younger patients presenting with ISE. When isolating the population statistics of trauma/surgery associated ISE in previous studies the older population also becomes more readily evident4,6. As the general population grows older, and more patients survive neurosurgical procedures there may be a shift in the epidemiology of patients with ISE2–5,9,11,18,20,23,24.

Other risk factors for developing ISE include smoking, diabetes, low socioeconomic status, and low health literacy25–27. However, the weight of these risk factors is yet to be established. Regardless, understanding the difference between the two population groups are important as it helps identify and assess them both uniquely.

Entrance of pathogens into the intracranial compartment can occur through multiple pathways. One such pathway is haematogenic from emboli via intracranial vessels such as diploe veins or endolymphatic channels3,28,29. As explained above, due to the anatomical differences, the younger male patient may be at a higher risk developing ISE from this pathway. The second pathway is from the suppurative process within the sinus and ear. The progressive infection causes osteomyelitis and direct invasion into the intracranial compartment2,3,22. This pathway is evident with the common location of the ISE being placed in the temporal lobe and cerebellum with identifiable areas of bone and dural defects adjacent to the ISE2,3,8,21. The third is direct inoculation, as seen in ISE associated with trauma and neurosurgical procedures.

The symptoms experienced are secondary to the presence of the infective collection causing mass effect to adjacent brain structures with associated inflammation. Within the subdural compartment, due to lack of physical constraints, the empyema is relatively free to spread over a larger area. The infection then poses a significant risk of venous stasis, venous thrombosis, cerebritis, and stroke over a large area of brain11,13,30. This can lead to rapid deterioration with symptoms presenting as early as 1 day or late as 6 weeks, with mean time of 15 days prior to clinical presentation1,5,8,13,31. Patients commonly experience headaches (77-83%), fevers (72-96%), altered sensorium (56-67%), vomiting (50%) and seizures (29-56%)4–6,8,16,17,20,29. The clinical triad commonly described of fevers, headaches and vomiting is only present in half of patients1,3,5,29.

Depending on the location of the disease, mass effect can lead to symptoms including papilledema, cranial nerve palsy and hemiparesis (48-96%)4–6,8,15–17,20,29. In contrast to the subdural empyema, epidural abscesses are walled off by strong dural adhesions and therefore tend to present later and are associated less with fevers, loss of consciousness and seizures20.

The pathogenesis and clinical presentation of precursor infections and associated conditions is outside the scope of this report. It is however, important to understand that the risk of developing ISE from sinusitis and otogenic infections remains significantly low < 0.1%2,3,22,28. Regardless, in cases of sinus and otogenic complications cranial imaging and thorough examination of ear, nose and throat should be carried out to exclude concurrent intracranial infections32,33.

Laboratory analysis of blood tests are non-specific and can show raised white cell count, C-reactive protein and erythrocyte sedimentation rate4,9,18,34. Blood cultures, although recommended, can have poor yield as low as 5%. This is likely a consequence of the blood brain barrier and significant localization of infection within the intracranial compartment5,8. As a result, it is recommended that intra-operative sampling and cultures are performed in all surgeries. These too can render a negative result and fail to yield growth in 7-53% of cases but, if not acquired might preclude vital pathogenic information. Failure of such growth can be secondary to sterile empyema from early administration of antibiotics or improper use of culture medium6,16,33. Invasive procedures such as lumbar puncture (LP) are not recommended as previous reports have shown significant risk of neurological deterioration and herniation6,17,32. When LP is indeed done, cerebrospinal fluid (CSF) gram stains, cultures, and cell counts indicate inflammation but lack any specific pattern for ISE14,15,17,32,35.

Diagnosis is confirmed radiologically with computed tomography (CT) scans being the initial recommended modality as they provide a prompt assessment. If an ISE is evident on CT scans there is usually appreciable visualization of the collection including associated brain injury, bony destruction and adjacent sinus and otogenic pathology. The empyema appears as a thin, hypodense subdural lesion with linear enhancement of the medial surface. The mass effect that is present is usually disproportionate to the volume of the abscess as the cerebritis and cerebral ischemia contribute greatly to oedema and subsequent mass effect than the volume of abscess itself34. Unfortunately, the CT scans can be normal in 63% of cases4,31,36. The false negative scans can be a consequence of early symptomology without appreciable evidence of change. In these cases, a routine repeats CT scan or magnetic resonance imaging (MRI) is warranted. MRI has greater sensitivity (93%) and is therefore the gold standard in all patients with suspicion of ISE31. It provides accurate information regarding the extent of infection as more than half of patients will have more than one intracranial complication at time of diagnosis3,22,31. MRI appearances show similar patterns as shown in CT scans. The empyema is represented as a T2 hyperintense collection in the subdural compartment with associated T1 hypointensity. Addition of gadolinium highlights the surrounding membrane of the empyema and diffusion weighted imaging typically demonstrates restricted diffusion37. Simultaneously, a magnetic resonance venography (MRV) can be done to assess for venous sinus thrombosis. The extent of cerebral oedema may also be more apparent on the MRI15,38.

Like many infections of the central nervous system, implementation of antibiotics should not be delayed and patients should be promptly treated with broad spectrum antibiotics in accordance to local hospital guidelines2,8. Prior to the advent of antibiotics mortality reached near 100% within 24-48 hours of presentation even after surgical drainage1–7. Introduction to antibiotics have decreased mortality and reduced the rates of complications in ISE to 15-41%2–4. Further improvements of investigations, such as CT scans, has reduced this lower to 4-15% which has been credited to assisting in early diagnosis1,7,8.

Infections are commonly polymicrobial. Streptococcus milleri group is over-presented in cultures but other streptococcus species, staphylococcus species and anaerobic gram positive and negative species are also present and have been cultured14,32,35,39,40. In certain population groups, fungal empyema are also a possibility21. In Australia, most departments would use a combination of a third-generation cephalosporin with metronidazole and vancomycin. This would provide broad spectrum cover for most pathogens including aerobic and anaerobic organisms41. In tropical areas such as our department in the Northern Territory, Australia, the prevalence of fungal infections and melioidosis has prompted the use of meropenem, amphotericin and vancomycin. In cases of negative cultures, continuation of empiric antibiotics may be required which is typically a period of 6 weeks, with a minimum of 2 weeks of intravenous antibiotics8,29,35,41.

Other medical management strategies include implementation of prophylactic anticonvulsants and medical therapy to maintain normal intracranial pressure1,15,29. This could include but not exclusive to elevation of head of bed, normocapnia and normotensive parameters1,41. Medical management alone however is infrequently adequate in the management of ISE15,35. It has been successful in small number of cases and may be suitable in minor collections with the option to transition to surgery in the event of early therapy failure10. Many surgeons will attest the mainstay of treatment of any abscess is and remains as surgical drainage. The drainage of the collection provides a substantial step towards source control and accelerates recovery. Depending on factors including collection characteristics, surgical expertise and patient’s clinical status, the surgical procedure can be in the form of burr-holes or craniotomy35,41–43. If the abscess is easily accessible, thin and non loculated, then burr-holes may be an option. However, patients treated with burr-holes have an increased risk of requiring additional procedures and/or conversion to craniotomy15,35. Our department approaches ISE more aggressively and we believe a craniotomy is warranted in most if not all cases. Craniotomy has the benefit of providing the option of assessment of loculations, removal of membranes, repair of dural breach as well as an adequate washout in the subdural compartment.

Intraoperatively, decision to remove the bone flap should be done by case to case basis. If there is contamination of bone with evident osteomyelitis, we would recommend closure without bone. This is the same if there are signs of raised intracranial pressure (ICP)29,43. In cases of concurrent sinus or otogenic infections we would recommend definitive treatment of underlying pathology preferable at the same time as the ISE treatment3.

Intracranial subdural empyema is an uncommon intracranial infection. Like other cranial infections, the morbidity and mortality are significantly high, but this can be reduced with prompt diagnosis and subsequent implementation of antibiotics and surgical drainage. The time to diagnosis is dependent on a high degree of suspicion and a good understanding of the clinical risk factors associated with ISE. Over the years the epidemiology and risk profile for our patients have shifted and understanding the reason behind this can help the clinician’s approach their patients on a case by case basis and improve patient outcomes.

  1. Bruner D, Littlejohn L, Pritchard A. Subdural Empyema Presenting with Seizure, Confusion, and Focal Weakness. West J Emerg Med. 2013; 13(6): 509-511. doi:10.5811/westjem.2012.5.11727
  2. Osma U, Cureoglu S, Hosoglu S. The complications of chronic otitis media: report of 93 cases. J Laryngol Otol. 2000; 114(2): 97-100.
  3. Penido NDO, Borin A, Iha LCN, et al. Intracranial complications of otitis media: 15 years of experience in 33 patients. Otolaryngol - Head Neck Surg. 2005; 132(1): 37-42. doi:10.1016/j.otohns.2004.08.007
  4. Hlavin ML, Kaminski HJ, Fenstermaker RA, et al. Intracranial Suppuration: A Modern Decade of Postoperative Subdural Empyema and Epidural Abscess. Neurosurgery. 1994; 34(6): 974-981. doi:10.1227/00006123-199406000-00004
  5. French H, Schaefer N, Hons M, et al. Intracranial Subdural Empyema : A 10-Year Case Series. 2014; 188-194.
  6. Dill SR, Cobbs CG, McDonald CK. Subdural empyema: Analysis of 32 cases and review. Clin Infect Dis. 1995; 20(2): 372-386. doi:10.1093/clinids/20.2.372
  7. Goldman SA, Ankerstjerne JKB, Welker KB, et al. Fatal meningitis and brain abscess resulting from foreign body-induced otomastoiditis. Otolaryngol - Head Neck Surg. 1998; 118(1): 6-8. doi:10.1016/S0194-5998(98)70367-5
  8. Madhugiri VS, Sastri BVS, Bhagavatula ID, et al. Posterior fossa subdural empyema in children-management and outcome. Child’s Nerv Syst. 2011; 27(1): 137-144. doi:10.1007/s00381-010-1169-z
  9. Widdrington JD, Bond H, Schwab U, et al. Pyogenic brain abscess and subdural empyema: presentation, management, and factors predicting outcome. Infection. 2018; 46(6): 785-792. doi:10.1007/s15010-018-1182-9
  10. Mauser HW, Ravijst RA, Elderson A, et al. Nonsurgical treatment of subdural empyema. Case report. J Neurosurg. 1985; 63(1): 128-130. doi:10.3171/jns.1985.63.1.0128
  11. Bernardini GL. Diagnosis and management of brain abscess and subdural empyema. Curr Neurol Neurosci Rep. 2004; 4(6): 448-456.
  12. Clayman GL, Adams GL, Paugh DR, et al. Intracranial complications of paranasal sinusitis a combined institutional review. Laryngoscope. 1991; 101(3): 234-239. doi:10.1288/00005537-199103000-00003
  13. Miller ES, Dias PS, Uttley D. Management of subdural empyema: a series of 24 cases. J Neurol Neurosurg Psychiatry. 1987; 50(11): 1415-1418. doi:10.1136/jnnp.50.11.1415
  14. McIntyre PB, Lavercombe PS, Kemp RJ, et al. Subdural and epidural empyema: diagnostic and therapeutic problems. Med J Aust. 1991; 154(10): 653-657.
  15. Osborn MK, Steinberg JP. Subdural empyema and other suppurative complications of paranasal sinusitis. Lancet Infect Dis. 2007; 7(1): 62-67. doi:10.1016/S1473-3099(06)70688-0
  16. Mauser HW, Tulleken CA. Subdural empyema. A review of 48 patients. Clin Neurol Neurosurg. 1984; 86(4): 255-263. doi:10.1016/0303-8467(84)90286-5
  17. Nathoo N, Nadvi SS, van Dellen JR, et al. Intracranial Subdural Empyemas in the Era of Computed Tomography: A Review of 699 Cases. Neurosurgery. 1999; 44(3): 529-535. doi:10.1097/00006123-199903000-00055
  18. Eggart MD, Greene C, Fannin ES, et al. A 14-year review of socioeconomics and sociodemographics relating to intracerebral abscess, subdural empyema, and epidural abscess in Southeastern Louisiana. Neurosurgery. 2016; 79(2): 265-269. doi:10.1227/NEU.0000000000001225
  19. Anagnostopoulos DI, Gortvai P. Intracranial subdural abscess. Br J Surg. 1973; 60(1): 50-52. doi:10.1002/bjs.1800600113
  20. Tsai YD, Chang WN, Shen CC, et al. Intracranial suppuration: A clinical comparison of subdural empyemas and epidural abscesses. Surg Neurol. 2003; 59(3): 191-196. doi:10.1016/S0090-3019(02)01054-6
  21. Yoon J, Redmond M. Check the Ear. The Importance of Ear Examinations in Assessment of Intracranial Subdural Empyema. Trop Med Infect Dis. 2019; 4(3): 120. doi:10.3390/tropicalmed4030120
  22. Sharma N, Jaiswal AA, Banerjee PK, et al. Complications of Chronic Suppurative Otitis Media and Their Management: A Single Institution 12 Years Experience. Indian J Otolaryngol Head Neck Surg. 2015; 67(4): 353-360. doi:10.1007/s12070-015-0836-5
  23. Guan J, Spivak ES, Wilkerson C, et al. Subdural Empyema in the Setting of Multimodal Intracranial Monitoring. World Neurosurg. 2017; 97: 749.e1-749.e6. doi:10.1016/j.wneu.2016.10.133
  24. Australian Bureau of Statistics. Population by Age and Sex, Regions of Australia 2010.; 2010. https://www.abs.gov.au/ausstats/abs@.nsf/Products/3235.0~2010~Main+Features~Queensland?OpenDocument.
  25. Bailie R, Stevens M, McDonald E, et al. Exploring cross-sectional associations between common childhood illness, housing and social conditions in remote Australian Aboriginal communities. BMC Public Health. 2010; 10. doi:10.1186/1471-2458-10-147
  26. Jacoby PA, Coates HL, Arumugaswamy A, et al. The effect of passive smoking on the risk of otitis media in Aboriginal and non-Aboriginal children in the Kalgoorlie-Boulder region of Western Australia. Med J Aust. 2008; 188(10): 599-603.
  27. Jervis-Bardy J, Sanchez L, Carney AS. Otitis media in indigenous australian children: Review of epidemiology and risk factors. J Laryngol Otol. 2014; 128(SUPPL.S1). doi:10.1017/S0022215113003083
  28. Wu JF, Jin Z, Yang JM, et al. Extracranial and intracranial complications of otitis media: 22-year clinical experience and analysis. Acta Otolaryngol. 2012; 132(3): 261-265. doi:10.3109/00016489.2011.643239
  29. De Bonis P, Anile C, Pompucci A, et al. Cranial and spinal subdural empyema. Br J Neurosurg. 2009; 23(3): 335-340. doi:10.1080/02688690902939902
  30. Holland AA, Morriss M, Glasier PC, et al. Complicated subdural empyema in an adolescent. Arch Clin Neuropsychol. 2013; 28(1): 81-91. doi:10.1093/arclin/acs104
  31. Germiller JA, Monin DL, Sparano AM, et al. Intracranial complications of sinusitis in children and adolescents and their outcomes. Arch Otolaryngol - Head Neck Surg. 2006; 132(9): 969-976. doi:10.1001/archotol.132.9.969
  32. Jones NS, Walker JL, Bassi S, et al. The intracranial complications of rhinosinusitis: Can they be prevented? Laryngoscope. 2002; 112(1): 59-63. doi:10.1097/00005537-200201000-00011
  33. Singh B, Ramjettan S, Dellen J Van, et al. Sinogenic intracranial complications. J Laryngol Otol. 1995; 109(10): 945-950. doi:10.1017/S0022215100131731
  34. Weisberg L. Subdural empyema. Clinical and computed tomographic correlations. Arch Neurol. 1986; 43(5): 497-500. doi:10.1001/archneur.1986.00520050069025
  35. Bok AP, Peter JC. Subdural empyema: burr holes or craniotomy? A retrospective computerized tomography-era analysis of treatment in 90 cases. J Neurosurg. 1993; 78(4): 574-578. doi:10.3171/jns.1993.78.4.0574
  36. Gupta S, Vachhrajani S, Kulkarni AV, et al. Neurosurgical management of extraaxial central nervous system infections in children. J Neurosurg Pediatr PED. 2011; 7(5): 441-451. doi:10.3171/2011.2.PEDS09500
  37. Tsuchiya K, Osawa A, Katase S, et al. Diffusion-weighted MRI of subdural and epidural empyemas. Neuroradiology. 2003; 45(4): 220-223. doi:10.1007/s00234-003-0949-5
  38. Younis RT, Anand VK, Davidson B. The role of computed tomography and magnetic resonance imaging in patients with sinusitis with complications. Laryngoscope. 2002; 112(2): 224-229. doi:10.1097/00005537-200202000-00005
  39. Jones RL, Violaris NS, Chavda SV, et al. Intracranial complications of sinusitis: the need for aggressive management. J Laryngol Otol. 1995; 109(11): 1061-1062. doi:10.1017/s0022215100132025
  40. Han JK, Kerschner JE. Streptococcus milleri: an organism for head and neck infections and abscess. Arch Otolaryngol Head Neck Surg. 2001; 127(6): 650-654. doi:10.1001/archotol.127.6.650
  41. Hendaus MA. Subdural empyema in children. Glob J Health Sci. 2013; 5(6): 54-59.
  42. Liu ZH, Chen NY, Tu PH, et al. The treatment and outcome of postmeningitic subdural empyema in infants. J Neurosurg Pediatr. 2010; 6(1): 38-42. doi:10.3171/2010.4.PEDS09433
  43. Bannister G, Williams B, Smith S. Treatment of subdural empyema. J Neurosurg. 1981; 55(1): 82-88. doi:10.3171/jns.1981.55.1.0082
 

Article Info

  • Journal of Infectiology
  • Article Type : Mini Review
  • View/Download pdf
  • DOI : 10.29245/2689-9981/2019/1.1149

Article Notes

  • Published on: January 10, 2020

Keywords

  • Intracranial infections

  • Subdural empyema
  • Clinical epidemiology
  • Intracranial abscess

*Correspondence:

Dr. Joseph Yoon
Department of Neurosurgery, Royal Darwin Hospital, PO Box 41326, Casuarina 0810, NT, Australia; Telephone No: 08 8922 8888
Email: joseph.yoon@nt.gov.au.

©2020 Yoon J. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License.